Targeted sequencing of cell-free DNA and white blood cells from 24 men with metastatic prostate cancer
This dataset consists of aligned DNA sequencing data in BAM file format from cell-free DNA and white blood cells from 24 men with metastatic prostate cancer. One cell-free DNA sample and one white blood cell sample is available for each patient, resulting in 48 total BAM files in this dataset. The sequencing was performed using a hybrid capture-based targeted panel of 73 prostate cancer driver genes.
- 48 samples
- DAC: EGAC00001001082
- Technology: Illumina HiSeq 2500
Data Access Policy for the targeted sequencing study included in the study "Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer".
A data access agreement (DAA), based on the example DAA provided by EGA, is to be filled out by the requester, and then by the data access committee (DAC) for the study "Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer".
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001003352 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.